LENSAR, Inc. (LNSR) stock
LNSRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3026% below fair value
$4.46−0.18 (-3.88%)
Close on Nov 20, 2026Market cap $54.80MP/E –Yield –
Lensar revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Lensar's revenue for the twelve months ending Jun 30, 2026 was $60.26M, up 3.3% year over year. For fiscal 2025 it was $58.44M, up 9.2% from the year before. The highest annual figure on record is $58.44M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $58.44M | +9.2% |
| FY2024 | Dec 31, 2024 | $53.49M | +26.9% |
| FY2023 | Dec 31, 2023 | $42.16M | +19.2% |
| FY2022 | Dec 31, 2022 | $35.36M | +2.6% |
| FY2021 | Dec 31, 2021 | $34.46M | +30.6% |
| FY2020 | Dec 31, 2020 | $26.38M | -13.6% |
| FY2019 | Dec 31, 2019 | $30.53M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $16.50M | +18.4% |
| Q1 FY2026 | Mar 31, 2026 | $13.43M | -5.2% |
| Q4 FY2025 | Dec 31, 2025 | $16.03M | -4.2% |
| Q3 FY2025 | Sep 30, 2025 | $14.32M | +5.7% |
| Q2 FY2025 | Jun 30, 2025 | $13.94M | +10.3% |
| Q1 FY2025 | Mar 31, 2025 | $14.16M | +33.7% |
| Q4 FY2024 | Dec 31, 2024 | $16.73M | +38.2% |
| Q3 FY2024 | Sep 30, 2024 | $13.54M | +38.2% |
| Q2 FY2024 | Jun 30, 2024 | $12.64M | +5.2% |
| Q1 FY2024 | Mar 31, 2024 | $10.59M | +28.3% |
| Q4 FY2023 | Dec 31, 2023 | $12.11M | +18.3% |
| Q3 FY2023 | Sep 30, 2023 | $9.80M | +26.4% |
| Q2 FY2023 | Jun 30, 2023 | $12.01M | +49.4% |
| Q1 FY2023 | Mar 31, 2023 | $8.25M | -11.6% |
| Q4 FY2022 | Dec 31, 2022 | $10.23M | -8.8% |
| Q3 FY2022 | Sep 30, 2022 | $7.75M | -6.3% |
| Q2 FY2022 | Jun 30, 2022 | $8.04M | +1.5% |
| Q1 FY2022 | Mar 31, 2022 | $9.34M | +32.6% |
| Q4 FY2021 | Dec 31, 2021 | $11.22M | +35.5% |
| Q3 FY2021 | Sep 30, 2021 | $8.27M | +15.8% |
| Q2 FY2021 | Jun 30, 2021 | $7.92M | +57.0% |
| Q1 FY2021 | Mar 31, 2021 | $7.04M | +19.3% |
| Q4 FY2020 | Dec 31, 2020 | $8.28M | -2.1% |
| Q3 FY2020 | Sep 30, 2020 | $7.15M | -11.4% |
| Q2 FY2020 | Jun 30, 2020 | $5.05M | – |
| Q1 FY2020 | Mar 31, 2020 | $5.91M | – |
| Q4 FY2019 | Dec 31, 2019 | $8.46M | – |
| Q3 FY2019 | Sep 30, 2019 | $8.07M | – |
See a number that looks wrong?